Skip to main content
Livermore
Livermore
ZHEN

Detalus Advisors, LLC

SEC CIK
0001799677
Latest filing
Jul 27, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Detalus Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
14,812
Value
$1.34M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABT by Detalus Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,812$1.34M0.3%+10.0%AddedHolders
Q1 202614,811$1.52M0.3%−278−1.8%ReducedHolders
Q4 202515,089$1.89M0.5%+10.0%AddedHolders
Q3 202515,088$2.02M0.5%−165−1.1%ReducedHolders
Q2 202515,253$2.07M0.6%00.0%UnchangedHolders
Q1 202515,253$2.02M0.6%+70.0%AddedHolders
Q4 202415,246$1.72M0.6%−29−0.2%ReducedHolders
Q3 202415,275$1.74M0.6%00.0%UnchangedHolders
Q2 202415,275$1.59M0.5%−347−2.2%ReducedHolders
Q1 202415,622$1.78M0.6%00.0%UnchangedHolders
Q4 202315,622$1.72M0.7%−20−0.1%ReducedHolders
Q3 202315,642$1.51M0.7%−980−5.9%ReducedHolders
Q2 202316,622$1.81M0.8%+384+2.4%AddedHolders
Q1 202316,238$1.64M0.8%−43−0.3%ReducedHolders
Q4 202216,281$1.79M0.9%+14,136+659.0%AddedHolders
Q3 20222,145$208.0K0.1%00.0%UnchangedHolders
Q2 20222,145$233.0K0.1%−585−21.4%ReducedHolders
Q1 20222,730$323.0K0.2%−300−9.9%ReducedHolders
Q4 20213,030$426.0K0.2%−784−20.6%ReducedHolders
Q3 20213,814$451.0K0.2%−45−1.2%ReducedHolders
Q2 20213,859$447.0K0.2%−112−2.8%ReducedHolders
Q1 20213,971$476.0K0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.